Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer
Author: Wheelwright, S.
Darlington, A.
Fitzsimmons, D.
Fayers, P.
Arraras, J.
Bonnetain, F.
Brain, E.
Bredart, A.
Chie, W.
Giesinger, J.
Hammerlid, E.
O'Connor, S.
Oerlemans, S.
Pallis, A.
Reed, M.
Singhal, N.
Vassiliou, V.
Young, T.
Johnson, C.
Citation: British Journal of Cancer, 2013; 109(4):852-858
Publisher: Cancer Research UK
Issue Date: 2013
ISSN: 0007-0920
Statement of
S Wheelwright, A-S Darlington, D Fitzsimmons, P Fayers, J I Arraras, F Bonnetain, E Brain, A Bredart, W-C Chie, J Giesinger, E Hammerlid, S J O, Connor, S Oerlemans, A Pallis, M Reed, N Singhal, V Vassiliou, T Young, and C Johnson, on behalf of the EORTC Quality of Life Group
Abstract: Background: Older people represent the majority of cancer patients but their specific needs are often ignored in the development of health-related quality of life (HRQOL) instruments. The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-ELD15 was developed to supplement the EORTC’s core questionnaire, the QLQ-C30, for measuring HRQOL in patients aged 470 years in oncology studies. Methods: Patients (n¼518) from 10 countries completed the QLQ-C30, QLQ-ELD15 and a debriefing interview. Eighty two clinically stable patients repeated the questionnaires 1 week later (test–retest analysis) and 107 others, with an expected change in clinical status, repeated the questionnaires 3 months later (response to change analysis, RCA). Results: Information from the debriefing interview, factor analysis and item response theory analysis resulted in the removal of one item (QLQ-ELD15-QLQ-ELD14) and revision of the proposed scale structure to five scales (mobility, worries about others, future worries, maintaining purpose and illness burden) and two single items (joint stiffness and family support). Convergent validity was good. In known-group comparisons, the QLQ-ELD14 differentiated between patients with different disease stage, treatment intention, number of comorbidities, performance status and geriatric screening scores. Test–retest and RCA analyses were equivocal. Conclusion: The QLQ-ELD14 is a validated HRQOL questionnaire for cancer patients aged X70 years. Changes in elderly patients’ self-reported HRQOL may be related to both cancer evolution and non-clinical events.
Keywords: health-related quality of life; elderly; European Organisation for Research and Treatment of Cancer QLQ-C30; module validation study
Description: Published online 18 July 2013
Rights: © 2013 Cancer Research UK. All rights reserved. This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution- NonCommercial-Share Alike 3.0 Unported License.
DOI: 10.1038/bjc.2013.407
Appears in Collections:Aurora harvest 3
Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_101842.pdfPublished Version253.05 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.